PBSV Stock Pharma-Bio Serv (PBSV, $0.6) Moving Average Convergence Divergence (MACD) Histogram turned negative on July 28, 2025
at Tickeron.com
PBSV's Stochastic Oscillator stays in overbought zone for 5 days
The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for PBSV turned negative on July 28, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 77 similar instances when the indicator turned negative. In of the 77 cases the stock turned lower in the days that followed. This puts the odds of success at .
PBSV broke above its upper Bollinger Band on July 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on July 11, 2025. You may want to consider a long position or call options on PBSV as a result. In of 151 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The 50-day moving average for PBSV moved above the 200-day moving average on July 09, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where PBSV advanced for three days, in of 81 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 92 cases where PBSV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PBSV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.319) is normal, around the industry mean (31.920). P/E Ratio (16.077) is within average values for comparable stocks, (166.002). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.749). Dividend Yield (0.000) settles around the average of (0.030) among similar stocks. P/S Ratio (1.137) is also within normal values, averaging (63.036).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PBSV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Advertisement
General Information
Industry PackagedSoftware